ORITAVANCIN Good Manufacturer supply High Quality 171099-57-3
- Molecular Formula:C86H97 Cl3 N10 O26
- Molecular Weight:1793.12
- PKA:2.93±0.70(Predicted)
- PSA:560.98000
- Density:1.59±0.1 g/cm3(Predicted)
- LogP:8.57000
ORITAVANCIN (171099-57-3) Usage
ORITAVANCIN is a semisynthetic glycopeptide antibiotic, which is utilized in the treatment of acute bacterial skin and skin structure infections. It is particularly effective against susceptible isolates of designated Gram-positive microorganisms, including Methicillin-resistant Staphylococcus aureus (MRSA). ORITAVANCIN functions by inhibiting bacterial cell wall synthesis, thereby preventing the growth and spread of the infection.
How to get the best price on ORITAVANCIN?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of ORITAVANCIN . You can buy high quality, low price ORITAVANCIN 171099-57-3 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches